NCT01438034View on ClinicalTrials.gov

Kisspeptin in the Evaluation of Delayed Puberty

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

June 8, 2013

Primary Completion Date

September 8, 2019

Study Completion Date

September 10, 2021

Conditions
Delayed PubertyKallmann SyndromeHypogonadotropic HypogonadismGnRH Deficiency
Interventions
DRUG

kisspeptin 112-121

0.24 nmol/kg

DRUG

GnRH

75 ng/kg

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
lead

Massachusetts General Hospital

OTHER

NCT01438034 - Kisspeptin in the Evaluation of Delayed Puberty | Biotech Hunter | Biotech Hunter